NovaBay Pharmaceuticals (NBY +7.2%) perks up on below-average volume in response to the online launch of its CelleRx skin and wound cleanser.
The company says CelleRx is based on the same pure hypochlorous acid formulation as flagship product Avenova.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.